B cells are associated with survival and immunotherapy response in sarcoma

Journal: Nature

Published: 2020-01-15

DOI: 10.1038/s41586-019-1906-8

Affiliations: 23

Authors: 29

Go to article
Institutions Share
Cordelier Research Center (CRC), France 0.20
Bergonié Cancer Institute, France 0.13
Laboratory of Integrative Cancer Immunology (ICI), France 0.11
Department of Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.09
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.09
Cartes d’Identité des Tumeurs (CIT), Ligue Contre Le Cancer, France 0.04
Department of Oncology, NTUH, Taiwan 0.04
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.03
Sarcoma Alliance for Research Through Collaboration (SARC), United States of America (USA) 0.03
Cancer Research And Biostatistics (CRAB), United States of America (USA) 0.03
Division of Hematology/Oncology, Pitt, United States of America (USA) 0.03
Department of General Oncology, MD Anderson Cancer Center, United States of America (USA) 0.03
Département de Biologie et Pathologie Médicales, IGR, France 0.03
Center of Genomic Medicine (CGM), NTU, Taiwan 0.03
Department of Pathology, NTUH, Taiwan 0.02
Institut Mondor de Recherche Biomédicale (IMRB), France 0.01
CHU Henri-Mondor, France 0.01
University of Bordeaux, France 0.01
National Taiwan University Cancer Center, NTU, Taiwan 0.01
Graduate Institute of Oncology, NTU, Taiwan 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER